Article
CA19-9 induces microenvironment remodeling in pancreatic ductal adenocarcinoma
2026-05-26
Abstract excerpt
<h4>ABSTRACT</h4> Durable therapeutic efficacy remains a major barrier to improving outcomes for patients with pancreatic ductal adenocarcinoma (PDAC). An immunosuppressive tumor microenvironment (TME) is a hallmark of PDAC and has been demonstrated to be a dominant driver of therapeutic resistance. The aberrant glycan CA19-9 is prevalent in PDAC and drives tumor progression, but the paracrine mechanisms by which...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bb1f2211-1d48-5eba-ac41-dac3fa7ab796
- DOI
- 10.64898/2026.05.22.727290
